home site map contact us
Deltagen
about deltagen
target discovery and validation
drug discovery
drug metabolism
pre clinical development
investor resources
news room

Other Information


Financial Statements and Notes - Third Quarter 2006
 

FINANCIAL STATEMENTS

DELTAGEN, INC.

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

Consolidated Balance Sheet

 

 

 

For Quarters ending 3/31/06, 6/30/06

 

 

 

& 9/30/06

Unaudited

Unaudited

Unaudited

 

 

(In Thousands)

03/31/06

06/30/06

09/30/06

 

 

 

Consolidated

Consolidated

Consolidated

Assets

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

            10,434

            10,789

            11,992

 

Accounts receivable, net

              1,561

              3,380

              1,808

 

Prepaids, Deposits and Tax Assets

                 490

                 642

                 701

 

 

Total current assets

            12,485

            14,811

            14,501

 

 

 

 

 

 

Property and equipment, net

                   84

                   73

                   73

 

 

 

 

 

 

Non-current portion of deferred tax assets

                 848

                 400

                 400

 

 

 

 

 

 

 

 

Total assets

            13,417

            15,284

            14,974

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders' Equity

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

              1,539

              1,590

              909

 

Accrued expenses

                 80

                 143

                 275

 

 

Total liabilities

              1,619

              1,733

              1,184

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

Common stock

                   39

                   39

                   39

 

Treasury Stock

               (867)

               (867)

               (867)

 

Additional paid-in capital

          238,648

217,223

          217,348

 

Additional paid-in capital - Stock-based compensation

                  -

21,548

21,548

 

Retained Earnings

        (226,089)

        (224,605)

        (224,468)

 

Foreign currency translation adjustment

                   67

                 211

                 190

 

 

Total stockholders' equity

            11,798

            13,549

            13,790

 

 

 

 

 

 

 

 

Total liabilities and stockholders' equity

            13,417

            15,282

            14,974

 

The accompanying notes are an integral part of these consolidated financial statements.

 

DELTAGEN, INC.

CONSOLIDATED INCOME STATEMENT

(UNAUDITED)

 

Consolidated Income Statement and

Statement of Retained Earnings

For Quarters ending 3/31/06, 6/30/06 & 9/30/06

 

 

 

Unaudited

Unaudited

Unaudited

(In Thousands)

03/31/06

06/30/06

09/30/06

 

Consolidated

Consolidated

Consolidated

 

 

 

 

Revenue

              1,882

              3,749

              970

Royalty and Commission Costs

                 493

              1,125

              246

Stock-Based Compensation Expense

-

123

123

Other Operating Costs

              1,063

                 767

                 590

 

 

 

 

Income From Operations

                 327

              1,734

              11

 

 

 

 

Interest Income

                 97

                   89

                   126

Loss on disposal of assets

                 (44)

                    -  

                    -  

 

 

 

 

Total Other Income

                   53

                   89

                   126

 

 

 

 

Income before provision for income taxes

                 380

              1,823

              137

 

 

 

 

Provision for income taxes

 

 

 

   Current income tax expense

                   11

                   39

                  -    

   Deferred income tax expense

                 152

                 817

                 -

   Adjustment for valuation allowance

                    -  

               (518)

               -

 

 

 

 

Total income tax expense

                 163

                 338

                 -

 

 

 

 

Net Income (Loss)

                 217

              1,485

              137

 

 

 

 

Retained earnings at beginning of period

        (226,306)

        (226,089)

        (224,605)

 

 

 

 

Retained earnings at end of period

        (226,089)

        (224,605)

        (224,468)

The accompanying notes are an integral part of these consolidated financial statements.


 

DELTAGEN, INC.

CONSOLIDATED CASH FLOW

(UNAUDITED)

 

 

Consolidated Cash Flow

 

 

For Quarters ending 3/31/06, 6/30/06 & 9/30/06

 

 

 

Unaudited

Unaudited

Unaudited

(In Thousands)

03/31/06

06/30/06

09/30/06

 

Consolidated

Consolidated

Consolidated

 

 

 

 

Cash flows from operating activities:

 

 

 

 

 

 

 

   Net Income

                 217

              1,485

              137

 

 

 

 

Adjustments to reconcile net income to net cash

 

 

used by operating activities

 

 

 

     Depreciation

                   11

                   11

                   -

     Loss on disposal of fixed assets

                   44

                    -  

                    -  

     Stock-based compensation expense

-

123

123

 

 

 

 

(Increase) / Decrease in operating assets

 

 

 

     Accounts receivable

                 926

            (1,819)

1,573

     Prepaids, deposits and tax assets

              1,165

               297

               (59)